Lyell Immunopharma, Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Lyell Immunopharma, Inc.
- Company name
- Lyell Immunopharma, Inc.
- Organisation type
- Industry
- Registered legal name
- Lyell Immunopharma, Inc.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- Headquarters country
- United States
- Publicly traded (proxy)
- Yes
- Listing at source
- Listed
- SEC filer number (CIK)
- 0001806952
Related records
Trials (7)
- A Biomarker Screening Protocol for Participants With Solid Tumors
- A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
- A Study to Investigate LYL797 in Adults With Solid Tumors
- A Study to Investigate LYL845 in Adults With Solid Tumors
- A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- LYL273 for Patients With Relapsed or Refractory mCRC
- Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma